Trial intelligence / Profile preview

Remimazolam vs propofol for anesthesia induction and maintenance in laparoscopic surgery

ChiCTR2600119912Phase 4Recruiting

Sponsor
Shouguang Traditional Chinese Medicine Hospital
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (2 arms), sponsored by Shouguang Traditional Chinese Medicine Hospital. Primary endpoint: Success rate of anesthesia induction. Started Feb 2026; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2600119912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600119912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call